106 related articles for article (PubMed ID: 12586599)
1. Specific inhibitors of protein phosphatase 2A inhibit tumor metastasis through augmentation of natural killer cells.
Kawada M; Kawatsu M; Masuda T; Ohba S; Amemiya M; Kohama T; Ishizuka M; Takeuchi T
Int Immunopharmacol; 2003 Feb; 3(2):179-88. PubMed ID: 12586599
[TBL] [Abstract][Full Text] [Related]
2. Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.
Swingle MR; Amable L; Lawhorn BG; Buck SB; Burke CP; Ratti P; Fischer KL; Boger DL; Honkanen RE
J Pharmacol Exp Ther; 2009 Oct; 331(1):45-53. PubMed ID: 19592665
[TBL] [Abstract][Full Text] [Related]
3. Cytostatin, an inhibitor of cell adhesion to extracellular matrix, selectively inhibits protein phosphatase 2A.
Kawada M; Amemiya M; Ishizuka M; Takeuchi T
Biochim Biophys Acta; 1999 Nov; 1452(2):209-17. PubMed ID: 10559474
[TBL] [Abstract][Full Text] [Related]
4. The potent protein phosphatase 2A inhibitors aminocytostatins: new derivatives of cytostatin.
Tohyama S; Kawada M; Muramatsu H; Hatano M; Inoue H; Matoba K; Sawa R; Igarashi M
J Antibiot (Tokyo); 2021 Oct; 74(10):743-751. PubMed ID: 34290381
[TBL] [Abstract][Full Text] [Related]
5. Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues.
Bialy L; Waldmann H
Chemistry; 2004 Jun; 10(11):2759-80. PubMed ID: 15195307
[TBL] [Abstract][Full Text] [Related]
6. Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibition.
Lawhorn BG; Boga SB; Wolkenberg SE; Colby DA; Gauss CM; Swingle MR; Amable L; Honkanen RE; Boger DL
J Am Chem Soc; 2006 Dec; 128(51):16720-32. PubMed ID: 17177422
[TBL] [Abstract][Full Text] [Related]
7. Rubratoxin A specifically and potently inhibits protein phosphatase 2A and suppresses cancer metastasis.
Wada S; Usami I; Umezawa Y; Inoue H; Ohba S; Someno T; Kawada M; Ikeda D
Cancer Sci; 2010 Mar; 101(3):743-50. PubMed ID: 20028386
[TBL] [Abstract][Full Text] [Related]
8. The PP2A inhibitor SET regulates natural killer cell IFN-gamma production.
Trotta R; Ciarlariello D; Dal Col J; Allard J; Neviani P; Santhanam R; Mao H; Becknell B; Yu J; Ferketich AK; Thomas B; Modi A; Blaser BW; Perrotti D; Caligiuri MA
J Exp Med; 2007 Oct; 204(10):2397-405. PubMed ID: 17875674
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and biological evaluation of cytostatin analogues.
Bialy L; Waldmann H
Chem Commun (Camb); 2003 Aug; (15):1872-3. PubMed ID: 12932009
[TBL] [Abstract][Full Text] [Related]
10. Zoledronic acid in combination with serine/threonine phosphatase inhibitors induces enhanced cytotoxicity and apoptosis in hormone-refractory prostate cancer cell lines by decreasing the activities of PP1 and PP2A.
Cirak Y; Varol U; Atmaca H; Kisim A; Sezgin C; Karabulut B; Uzunoglu S; Uslu R; Karaca B
BJU Int; 2012 Dec; 110(11 Pt C):E1147-54. PubMed ID: 22882676
[TBL] [Abstract][Full Text] [Related]
11. Cytostatin, a novel inhibitor of cell adhesion to components of extracellular matrix produced by Streptomyces sp. MJ654-NF4. I. Taxonomy, fermentation, isolation and biological activities.
Amemiya M; Ueno M; Osono M; Masuda T; Kinoshita N; Nishida C; Hamada M; Ishizuka M; Takeuchi T
J Antibiot (Tokyo); 1994 May; 47(5):536-40. PubMed ID: 8040050
[TBL] [Abstract][Full Text] [Related]
12. Anti-CD40 antibody induces antitumor and antimetastatic effects: the role of NK cells.
Turner JG; Rakhmilevich AL; Burdelya L; Neal Z; Imboden M; Sondel PM; Yu H
J Immunol; 2001 Jan; 166(1):89-94. PubMed ID: 11123280
[TBL] [Abstract][Full Text] [Related]
13. Interleukin-10 inhibits tumor metastasis through an NK cell-dependent mechanism.
Zheng LM; Ojcius DM; Garaud F; Roth C; Maxwell E; Li Z; Rong H; Chen J; Wang XY; Catino JJ; King I
J Exp Med; 1996 Aug; 184(2):579-84. PubMed ID: 8760811
[TBL] [Abstract][Full Text] [Related]
14. Prophylactic effect of Korean mistletoe (Viscum album coloratum) extract on tumor metastasis is mediated by enhancement of NK cell activity.
Yoon TJ; Yoo YC; Kang TB; Baek YJ; Huh CS; Song SK; Lee KH; Azuma I; Kim JB
Int J Immunopharmacol; 1998; 20(4-5):163-72. PubMed ID: 9730252
[TBL] [Abstract][Full Text] [Related]
15. The inhibition of protein phosphatases 1 and 2A: a new target for rational anti-cancer drug design?
McCluskey A; Ackland SP; Gardiner E; Walkom CC; Sakoff JA
Anticancer Drug Des; 2001 Dec; 16(6):291-303. PubMed ID: 12375882
[TBL] [Abstract][Full Text] [Related]
16. Antitumor activity of the Korean mistletoe lectin is attributed to activation of macrophages and NK cells.
Yoon TJ; Yoo YC; Kang TB; Song SK; Lee KB; Her E; Song KS; Kim JB
Arch Pharm Res; 2003 Oct; 26(10):861-7. PubMed ID: 14609136
[TBL] [Abstract][Full Text] [Related]
17. Inhibitory effect of MD-Fraction on tumor metastasis: involvement of NK cell activation and suppression of intercellular adhesion molecule (ICAM)-1 expression in lung vascular endothelial cells.
Masuda Y; Murata Y; Hayashi M; Nanba H
Biol Pharm Bull; 2008 Jun; 31(6):1104-8. PubMed ID: 18520039
[TBL] [Abstract][Full Text] [Related]
18. Immunomodulatory activity of a novel nucleoside, 7-thia-8-oxoguanosine: I. Activation of natural killer cells in mice.
Sharma BS; Mhaskar S; Balazs L; Siaw M
Immunopharmacol Immunotoxicol; 1992; 14(1-2):1-19. PubMed ID: 1597650
[TBL] [Abstract][Full Text] [Related]
19. Regulation of immunoglobulin E-mediated secretion by protein phosphatases in human basophils and mast cells of skin and lung.
Bastan R; Peirce MJ; Peachell PT
Eur J Pharmacol; 2001 Oct; 430(1):135-41. PubMed ID: 11698073
[TBL] [Abstract][Full Text] [Related]
20. Protein phosphatase-2A regulates protein tyrosine phosphatase activity in Lewis lung carcinoma tumor variants.
Jackson JL; Young MR
Clin Exp Metastasis; 2003; 20(4):357-64. PubMed ID: 12856723
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
